Collins Jennifer J P, Möbius Marius A, Thébaud Bernard
Sinclair Centre for Regenerative Medicine, Ottawa Hospital Research Institute; University of Ottawa;
Sinclair Centre for Regenerative Medicine, Ottawa Hospital Research Institute; Department of Neonatology and Pediatric Critical Care Medicine, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden; DFG Research Center and Cluster of Excellence for Regenerative Therapies (CRTD), Technische Universität, Dresden.
J Vis Exp. 2016 Jun 17(112):53782. doi: 10.3791/53782.
Mesenchymal stromal cells (MSCs) are increasingly recognized for their therapeutic potential in a wide range of diseases, including lung diseases. Besides the use of bone marrow and umbilical cord MSCs for exogenous cell therapy, there is also increasing interest in the repair and regenerative potential of resident tissue MSCs. Moreover, they likely have a role in normal organ development, and have been attributed roles in disease, particularly those with a fibrotic nature. The main hurdle for the study of these resident tissue MSCs is the lack of a clear marker for the isolation and identification of these cells. The isolation technique described here applies multiple characteristics of lung resident MSCs (L-MSCs). Upon sacrifice of the rats, lungs are removed and rinsed multiple times to remove blood. Following mechanical dissociation by scalpel, the lungs are digested for 2-3 hr using a mix of collagenase type I, neutral protease and DNase type I. The obtained single cell suspension is subsequently washed and layered over density gradient medium (density 1.073 g/ml). After centrifugation, cells from the interphase are washed and plated in culture-treated flasks. Cells are cultured for 4-7 days in physiological 5% O2, 5% CO2 conditions. To deplete fibroblasts (CD146(-)) and to ensure a population of only L-MSCs (CD146(+)), positive selection for CD146(+) cells is performed through magnetic bead selection. In summary, this procedure reliably produces a population of primary L-MSCs for further in vitro study and manipulation. Because of the nature of the protocol, it can easily be translated to other experimental animal models.
间充质基质细胞(MSCs)在包括肺部疾病在内的多种疾病中的治疗潜力日益受到认可。除了使用骨髓和脐带间充质基质细胞进行外源性细胞治疗外,人们对驻留组织间充质基质细胞的修复和再生潜力也越来越感兴趣。此外,它们可能在正常器官发育中发挥作用,并且在疾病,特别是纤维化性质的疾病中也被认为具有一定作用。研究这些驻留组织间充质基质细胞的主要障碍是缺乏用于分离和鉴定这些细胞的明确标志物。这里描述的分离技术利用了肺驻留间充质基质细胞(L-MSCs)的多种特性。在处死大鼠后,取出肺并多次冲洗以去除血液。用手术刀进行机械解离后,使用I型胶原酶、中性蛋白酶和I型脱氧核糖核酸酶的混合物将肺消化2-3小时。随后将获得的单细胞悬液洗涤并铺在密度梯度培养基(密度1.073 g/ml)上。离心后,将界面处的细胞洗涤并接种到经过培养处理的培养瓶中。细胞在生理5% O2、5% CO2条件下培养4-7天。为了去除成纤维细胞(CD146(-))并确保仅为L-MSCs(CD146(+))群体,通过磁珠选择对CD146(+)细胞进行阳性选择。总之,该程序可靠地产生了用于进一步体外研究和操作的原代L-MSCs群体。由于该方案的性质,可以很容易地将其转化为其他实验动物模型。